Trials / Completed
CompletedNCT03269175
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 261 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to obtain long-term clinical data from patients approximately 15 years after their first clinical event, who participated in the former BENEFIT 304747 study and were treated at least once within that study. This study will collect clinical information on the disease course, on disability, relapses, cognitive function over time, quality of life, depression, fatigue, resource use, and employment status. In addition, brain MRI is performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Brain MRI | Brain MRI will be performed |
| OTHER | Blood sampling | Blood samples will be taken |
Timeline
- Start date
- 2017-09-29
- Primary completion
- 2018-05-24
- Completion
- 2018-05-24
- First posted
- 2017-08-31
- Last updated
- 2019-05-16
Locations
61 sites across 18 countries: Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Norway, Poland, Portugal, Spain, Sweden, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT03269175. Inclusion in this directory is not an endorsement.